pI: 6.3718 |
Length (AA): 682 |
MW (Da): 74004 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 2 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
10 | 586 | 1jy1 (A) | 158 | 594 | 33.00 | 0 | 1 | 0.750041 | 0.81 |
117 | 534 | 1jy1 (A) | 220 | 543 | 36.00 | 0 | 0.82 | 0.554503 | 1.22 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_129037)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G15170 | tyrosyl-DNA phosphodiesterase 1 |
Brugia malayi | Bm1_36420 | Tyrosyl-DNA phosphodiesterase family protein |
Caenorhabditis elegans | CELE_F52C12.1 | Protein F52C12.1 |
Cryptosporidium hominis | Chro.70273 | hypothetical protein |
Cryptosporidium parvum | cgd7_2390 | tyrosyl-DNA phodphodiesterase 1 (tdp1) |
Drosophila melanogaster | Dmel_CG8825 | glaikit |
Echinococcus granulosus | EgrG_000433000 | transcription factor Dp 1 |
Echinococcus granulosus | EgrG_000433100 | tyrosyl DNA phosphodiesterase 1 |
Entamoeba histolytica | EHI_148390 | tyrosyl-DNA phosphodiesterase, putative |
Echinococcus multilocularis | EmuJ_000433000 | transcription factor Dp 1 |
Echinococcus multilocularis | EmuJ_000433100 | tyrosyl DNA phosphodiesterase 1 |
Homo sapiens | ENSG00000042088 | tyrosyl-DNA phosphodiesterase 1 |
Leishmania braziliensis | LbrM.33.3330 | tyrosyl-DNA phosphodiesterase, putative;with=GeneDB:LinJ33_V3.3210 |
Leishmania donovani | LdBPK_333210.1 | tyrosyl-DNA phosphodiesterase-like protein |
Leishmania infantum | LinJ.33.3210 | tyrosyl-DNA phosphodiesterase 1 |
Leishmania major | LmjF.33.3050 | tyrosyl-DNA phosphodiesterase 1 |
Leishmania mexicana | LmxM.32.3050 | tyrosyl-DNA phosphodiesterase-like protein |
Loa Loa (eye worm) | LOAG_02315 | tyrosyl-DNA phosphodiesterase |
Mus musculus | ENSMUSG00000021177 | tyrosyl-DNA phosphodiesterase 1 |
Oryza sativa | 4343446 | Os07g0530100 |
Saccharomyces cerevisiae | YBR223C | tyrosyl-DNA phosphodiesterase 1 |
Schistosoma japonicum | Sjp_0012210 | ko:K01113 phosphodiesterase/alkaline phosphatase D [EC3.1.4.1], putative |
Schistosoma mansoni | Smp_129800 | tyrosyl-DNA phosphodiesterase |
Schmidtea mediterranea | mk4.008114.01 | |
Schmidtea mediterranea | mk4.006310.01 | |
Schmidtea mediterranea | mk4.024191.00 | Probable tyrosyl-DNA phosphodiesterase |
Schmidtea mediterranea | mk4.006310.00 | Tyrosyl-DNA phosphodiesterase 1 |
Schmidtea mediterranea | mk4.002468.00 | E2F dimerization protein |
Trypanosoma brucei gambiense | Tbg.972.2.4040 | tyrosyl-DNA Phosphodiesterase (Tdp1), putative |
Trypanosoma brucei | Tb927.2.5750 | tyrosyl-DNA Phosphodiesterase (Tdp1), putative |
Trypanosoma congolense | TcIL3000_0_25380 | tyrosyl-DNA Phosphodiesterase (Tdp1), putative |
Trypanosoma cruzi | TcCLB.506619.40 | tyrosyl-DNA Phosphodiesterase (Tdp1), putative |
Trypanosoma cruzi | TcCLB.511191.10 | tyrosyl-DNA Phosphodiesterase (Tdp1), putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.2.5750 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.2.5750 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.2.5750 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.2.5750 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | tyrosyl-DNA phosphodiesterase 1 | Compounds | References |